Browse studies
Find your next paid study
52 recruiting studies matching your filters
Phase 2
Phase IIa Trial Evaluating the Safety and Therapeutic Effect of SMS001 as an Adjuvant Therapy to Control Tumor Recurrence in Stage Ib-IIIa (N2) Non-Small Cell Lung Cancer (NSCLC) Patients
This study evaluates the use of SMS001 in patients with lung cancer. SMS001 is a new form of drug Paclitaxel. Doctors want to decide an appropriate safe dose f…
Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)
Estimated
~$10 – $8,750
ToLymph Inc.NCT06693336
Observational
Engagement of Veterans With Lung Cancer (EVLC)
This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.
Lung Cancer (NSCLC)Lung AdenocarcinomaLung Cancer, Non-Small Cell+3 more
Estimated
~$10 – $5,625
Palo Alto Veterans Institute for ResearchNCT07219251
Phase 1
Study of the Immunogenicity of the MUC1 Peptide - Poly-ICLC (Polyinosinic-polycytidylic Acid Stabilized With Polylysine and Carboxymethylcellulose) OR HILTONOL™ Adjuvant Vaccine in Patients With Localized and Locally Advanced Non-Small Cell Lung Cancer
All subjects will receive the vaccine subcutaneously every 3 weeks x 3 with optional yearly booster vaccines up to and including 5 years post last vaccine for …
Non-small Cell Lung Cancer (NSCLC)
Estimated
~$10 – $7,500
Olivera FinnNCT01720836
Phase 1
Phase 1b/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Patients With Advanced KRAS G12C-Mutated Solid Tumors
This study is to evaluate the safety, tolerability, and PK profiles of Elironrasib and Daraxonrasib as monotherapies and combination therapy in patients with K…
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Estimated
~$10 – $8,750
Revolution Medicines, Inc.NCT06128551